{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "MYO1G",
                "DNA Alteration": "c.145G>A",
                "GeneMutation": "p.V49M Spliceregionvariant-LOF",
                "VariantAlleleFraction": "3.55%"
            },
            {
                "Gene": "APC",
                "DNA Alteration": "c.3920T>A",
                "GeneMutation": "p.I1307K Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.03%"
            },
            {
                "Gene": "KRAS",
                "DNA Alteration": "c.38G>C",
                "GeneMutation": "p.Q61H Stopgain-LOF",
                "VariantAlleleFraction": "2.78%"
            },
            {
                "Gene": "MAPK1",
                "DNA Alteration": "c.964G>A",
                "GeneMutation": "p.E322K Stopgain-LOF",
                "VariantAlleleFraction": "1.87%"
            },
            {
                "Gene": "BLM",
                "DNA Alteration": "c.2207_2212delinsTAGATTC",
                "GeneMutation": "p.Y736fs*4 Nonsense-LOF",
                "VariantAlleleFraction": "8.75%"
            },
            {
                "Gene": "MYO1G",
                "DNA Alteration": "c.145G>A",
                "GeneMutation": "p.V49M Nonsense-GOF",
                "VariantAlleleFraction": "9.39%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A572G Spliceregionvariant-GOF",
                "VariantAlleleFraction": "7.86%"
            },
            {
                "Gene": "FBXW7",
                "DNA Alteration": "c.1394G>A",
                "GeneMutation": "p.R465H Nonsense-GOF",
                "VariantAlleleFraction": "5.07%"
            },
            {
                "Gene": "HBB",
                "DNA Alteration": "c.20A>T",
                "GeneMutation": "p.E7V Frameshift-LOF",
                "VariantAlleleFraction": "2.41%"
            },
            {
                "Gene": "ZEB2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.H1038R Nonsense-GOF",
                "VariantAlleleFraction": "3.73%"
            }
        ],
        "Germline": []
    }
}